Journal of Oncology / 2021 / Article / Tab 3 / Research Article
Construction, Validation, and Visualization of Two Web-Based Nomograms to Predict Overall and Cancer-Specific Survival in Patients with Gastric Cancer and Lung Metastases Table 3 Univariate and multivariate Cox proportional hazards regression analysis of patients with GCLM in the OS group.
Variables Univariate Cox regression analysis Multivariate Cox regression analysis HR (95% CI) HR (95% CI) Age <60 Reference ≥60 1.044 (0.854–1.277) 0.671 Race Black Reference Other 0.979 (0.658–1.457) 0.918 White 0.788 (0.586–1.061) 0.117 Sex Female Reference Male 0.99 (0.799–1.225) 0.923 Histologic type Adenocarcinoma Reference Signet ring cell 1.044 (0.786–1.388) 0.765 Intestinal type 1.358 (0.901–2.047) 0.144 Other 1.144 (0.873–1.498) 0.33 T stage T1 Reference T2 0.705 (0.459–1.083) 0.11 T3 0.944 (0.735–1.214) 0.656 T4 1.219 (0.969–1.535) 0.091 N stage N0 Reference N1 1.009 (0.820–1.243) 0.929 N2 0.961 (0.664–1.391) 0.833 N3 1.166 (0.790–1.721) 0.44 Grade Grade I Reference Reference Grade II 1.458 (0.850–2.501) 0.171 1.275 (0.738–2.201) 0.383 Grade III 1.864 (1.105–3.144) 0.02 1.896 (1.118–3.214) 0.018 Grade IV 1.238 (0.410–3.743) 0.705 0.942 (0.310–2.864) 0.916 Bone metastasis No Reference Yes 1.075 (0.833–1.388) 0.58 Liver metastasis No Reference Yes 1.309 (1.080–1.587) 0.006 1.440 (1.179–1.760) <0.001 Brain metastasis No Reference Yes 1.434 (0.806–2.550) 0.22 Primary site Cardia Reference Fundus 1.487 (0.956–2.315) 0.079 Body 1.179 (0.792–1.754) 0.418 Gastric antrum 1.224 (0.893–1.676) 0.208 Lesser 1.211 (0.764–1.922) 0.416 Greater 1.182 (0.737–1.895) 0.488 Other 1.28 (0.995–1.646) 0.054 Radiotherapy No Reference Yes 0.761 (0.606–0.955) 0.019 0.979 (0.770–1.244) 0.859 Chemotherapy No Reference Yes 0.312 (0.253–0.384) <0.001 0.292 (0.235–0.363) <0.001 Surgery No Reference Yes 0.835 (0.598–1.167) 0.291 Marital status No Reference Yes 0.844 (0.694–1.025) 0.087 Insurance No Reference Yes 1.076 (0.723–1.602) 0.718